Sanofi India · NSE: SANOFI · BSE: 500674
Q2 FY23 results · Jul–Sep 2022
Sanofi India reported revenue from operations of ₹691.90 crore (down 8.3% from Q2 FY22) and net profit of ₹130.90 crore (down 75.3% from Q2 FY22) for Q2 FY23 (Jul–Sep 2022), on a standalone basis.
| Item | Q2 FY23 | Q2 FY22 | YoY | Q1 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 691.90 | 754.50 | −8.3% | 699.30 | −1.1% |
| Other income | 11.40 | 14.70 | −22.4% | 15.70 | −27.4% |
| Total income | 703.30 | 769.20 | −8.6% | 715.00 | −1.6% |
| Profit before tax | 182.40 | 687.90 | −73.5% | 165.80 | +10.0% |
| Net profit for the period | 130.90 | 529.80 | −75.3% | 120.40 | +8.7% |
| EPS, basic (₹) | 56.84 | 230.04 | −75.3% | 52.28 | +8.7% |
| Net margin (%) | 18.9 | 70.2 | 17.2 |
Standalone
- Filed with BSE
- 04 Nov 2022, 18:26 IST
- Board meeting
- 03 Nov 2022
- Period
- 01 Jul 2022 to 30 Sep 2022
- Review status
- Unaudited
- Source
- XBRL filing on BSE